Solicitor's certificate of service on behalf of Livia Aumand confirming service of document #46 upon Roche Diagnostics and Novartis AG by personal service on 12-FEB-2014 confirming service #46 upon Taro Pharmaceuticals Inc by telecopier on 12-FEB-2014 confirming service #46 upon Minister of Health by telecopier on 12-FEB-2014 filed on 12-FEB-2014

Discontinuance with Consent on behalf of Applicant with consent on behalf of all parties filed on 12-FEB-2014

Acknowledgment of Receipt received from all parties (by fax) with respect to doc 45 placed on file on 09-JAN-2014

Order (time and place) dated 09-JAN-2014 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Ottawa on 17-JUL-2014 to begin at 09:30 duration: 2d language: E Filed on 09-JAN-2014 cc's sent to parties entered in J. & O. Book, volume 1216 page(s) 107 - 108 Transmittal letters placed on file

Communication to the Court from the Registry dated 11-DEC-2013 re: Doc. No. 43

Solicitor's certificate of service on behalf of Livia Aumand confirming service of Requisition for Hearing upon all parties by telecopier on 09-DEC-2013 filed on 09-DEC-2013

Requisition for hearing - Application from Applicant filed on 09-DEC-2013 Tariff Application or appeal - $50.00

Covering letter from RESPONDENT-TARO PHARMACEUTICALS INC. dated 18-NOV-2013 concerning Doc. Nos. 41 42 placed on file on 18-NOV-2013

Solicitor's certificate of service on behalf of KAVITA RAMAMOORTHY confirming service of DOC 41 upon APPLICANT,NOVARTIS PHARM CANADA and RESPONDENTS/PATENTEES,NOVARTIS and ROCHE by COURIER on 15-NOV-2013 confirming service DOC 41 upon RESPONDENT, MINISTER OF HEALTH by COURIER on 15-NOV-2013 filed on 18-NOV-2013

Affidavit of LUL OGBA-GHEBRIEL sworn on 14-NOV-2013 on behalf of RESPONDENT-TARO PHARMACEUTICALS INC. RULE 307 EVIDENCE filed on 18-NOV-2013

Acknowledgment of Receipt received from all parties with respect to Order Doc. 40 Transmitted by e-mail on 3-OCT-2013: receipt acknowledged by the Applicant and the Respondent Taro Pharmaceuticals Inc. on 3-OCT-2013; by the Respondent Minister of Health on 7-OCT-2013. placed on file on 07-OCT-2013

Order dated 03-OCT-2013 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 21 Result: dismissed - with costs in the amount of $5,000.00 Filed on 03-OCT-2013 copies sent to parties entered in J. & O. Book, volume 1206 page(s) 198 - 201 Interlocutory Decision

Ottawa 18-SEP-2013 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 21 on behalf of Respondent (motion to dismiss) Result of Hearing: Matter dismissed costs in the amount of 5000$ held in Court Senior Usher: Mr. Daniel Cormier Duration per day: 18-SEP-2013 from 09:30 to 12:10 Courtroom : Courtroom No. 2, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Victoria Bell Total Duration: 2h 40 mins Appearances: Ms. Kavita Ramamoorthy 416-941-9607 representing Respondent Mr. Anthony Creber / Ms. Livia Aumand 613-786-0140 representing Applicant Comments: The Respondent provided the Court with a copy of the Notice of Application and a Supplementary Book of Authorities This hearing was recorded using the DARS M-Audio Fast Track Ultra 8R system. Minutes of Hearing entered in Vol. 887 page(s) 39 - 59 Abstract of Hearing placed on file

Supplementary Book of Authorities (received at hearing) consisting of 1 volume(s) on behalf of Respondent received on 18-SEP-2013 Sent directly to Presiding Judge

Solicitor's certificate of service on behalf of Livia Aumand confirming service of docs. 37, 38 and authorities upon all parties by personal service and courier on 13-SEP-2013 filed on 13-SEP-2013

Book of Authorities consisting of 2 volume(s) on behalf of Applicant received on 13-SEP-2013

Sealed envelope pursuant to confidentiality order on behalf of Applicant purporting to contain confidential volumes 1 and 2 of applicant's motion record doc. 37 Filed on 13-SEP-2013

Motion Record in response to Motion Doc. No. 21 containing the following original document(s): 27 28 29 30 31 32 33 34 35 36 Number of copies received: 3 on behalf of Applicant filed on 13-SEP-2013

Written Representations on behalf of Applicant concerning Motion Doc. No. 21 filed on 13-SEP-2013

Affidavit of Erin McIntomny sworn on 21-AUG-2013 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 21 with Exhibits A filed on 13-SEP-2013

Affidavit of David Goltzman sworn on 29-APR-2013 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 21 with Exhibits A to G filed on 13-SEP-2013

Affidavit of John D. MacDonald sworn on 30-APR-2013 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 21 with Exhibits A to KK filed on 13-SEP-2013

Affidavit of Farley Cohen sworn on 30-APR-2013 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 21 with Exhibits A to C filed on 13-SEP-2013

Affidavit of Erin McIntomny sworn on 02-MAY-2013 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 21 with Exhibits A to D filed on 13-SEP-2013

Affidavit of Jean Desforges sworn on 26-APR-2013 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 21 with Exhibits A to J filed on 13-SEP-2013

Affidavit of Luc Bergeron sworn on 29-APR-2013 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 21 with Exhibits A to D filed on 13-SEP-2013

Affidavit of Kelly Anderson sworn on 25-APR-2013 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 21 with Exhibits A filed on 13-SEP-2013

Affidavit of Isabelle Pinsonnault sworn on 29-APR-2013 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 21 with Exhibits A to F filed on 13-SEP-2013

Solicitor's certificate of service on behalf of KAVITA RAMAMOORTHY confirming service of MOTION RECORD (DOC. 24) AND BOOK OF AUTHORITIES upon RESPONDENT - TARO; RESPONDENTS/PATENTEES - NOVARTIS AG AND ROCHE DIAGNOSTICS by COURIER on 16-AUG-2013 confirming service MOTION RECORD (DOC. 24) AND BOOK OF AUTHORITIES upon RESPONDENT - MOH by COURIER on 15-AUG-2013 filed on 16-AUG-2013

PUBLIC VERSION OF MOTION RECORD (DOC. 24) (ONLY V. 1 AND V. 2 OF 4 PROVIDED) filed on 16-AUG-2013

BOOK OF AUTHORITIES (RE: NOTICE OF MOTION DOC. 21) consisting of 1 volume(s) on behalf of RESPONDENT - TARO PHARMACEUTICALS received on 16-AUG-2013

Motion Record containing the following original document(s): 21 22 23 Number of copies received: 3 on behalf of RESPONDENT - TARO PHARMACEUTICALS INC. (4 VOLS. - V.1 AND V. 2 CONFIDENTIAL) filed on 16-AUG-2013

Written Representations contained within a Motion Record on behalf of RESPONDENT - TARO PHARMACEUTICALS concerning Motion Doc. No. 21 filed on 16-AUG-2013

Affidavit of SUMAIYA SHARMEEN sworn on 27-JUN-2013 contained within a Motion Record on behalf of RESPONDENT - TARO PHARMACEUTICALS in support of Motion Doc. No. 21 with Exhibits SS-A TO SS-K filed on 16-AUG-2013

Notice of Motion contained within a Motion Record on behalf of RESPONDENT - TARO PHARMACEUTICALS returnable at Special Sitting in Ottawa on 18-SEP-2013 to begin at 09:30 for an Order PURSUANT TO SECTION 6(5)(B) OF THE PM(NOC) REGULATIONS DISMISSING THIS APPLICATION IN WHOLE AND OTHER RELIEF. filed on 16-AUG-2013

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Confidentiality Order dated August 9, 2013 placed on file on 09-AUG-2013

CONFIDENTIALITY ORDER dated 09-AUG-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 01-AUG-2013 re: requesting a Confidentiality Order on consent of the parties Result: granted Filed on 09-AUG-2013 copies sent to parties entered in J. & O. Book, volume 1201 page(s) 448 - 450 Interlocutory Decision

Communication to the Court from the Registry dated 02-AUG-2013 re: letters received from the Applicant and Respondent on August 1, 2013

Letter from Respondent dated 01-AUG-2013 further to the CMC which took place on July 15, 2013 requesting the designation of material as confidential. The Respondents request that the draft Confidentiality Order submitted by the Applicants on August 1, 2013 be issued. received on 01-AUG-2013

Affidavit of Kyle Steiger sworn on 17-JUL-2013 on behalf of Applicant in support of Novartis' request that certain info be designated confidential filed on 01-AUG-2013

Letter from Applicant dated 01-AUG-2013 further to the CMC on July 15, 2013 advising that they are submitting the Affidavit of Kyle Steiger in support of Novartis' request that certain information included in its evidence be kept confidential. The Applicant advises that the parties have agreed to the form of a draft Confidentiality Order which is enclosed. received on 01-AUG-2013

Acknowledgment of Receipt received from all parties with respect to Order Doc. 18 Transmitted by e-mail on 16-JUL-2013: receipt acknowledged by the Applicant and the Respondent Taro Pharmaceuticals Inc. on 16-JUL-2013; by the Respondent Minister of Health on 17-JUL-2013 placed on file on 17-JUL-2013

Order dated 16-JUL-2013 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: The following schedule will apply to Taro's Motion pursuant to s. 6(5)(b) of the Patented Medicines (Notice of Compliance) Regulations: 1. Taro's full Motion Record shall be served and filed by 16-AUG-2013. 2. Novartis' responding evidence shall be served by 21-AUG-2013. 3. Cross-examinations shall be completed by 26-AUG-2013. 4. Novartis' full responding Motion Record shall be served and filed by 13-SEP-2013. 5. A hearing shall take place in Ottawa beginning at 9:30 a.m. on 18-SEP-2013. Filed on 16-JUL-2013 copies sent to parties entered in J. & O. Book, volume 1199 page(s) 375 - 376 Interlocutory Decision

Ottawa 15-JUL-2013 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Order to issue held in chambers by way of Conference Call Duration per day: 15-JUL-2013 from 15:40 to 16:05 Courtroom : Judge's Chambers - Ottawa Court Registrar: Alison Dickenson Total Duration: 25 minutes Appearances: Livia Aumand and Jennifer Wilkie (613) 786-0112 representing Applicant Kavita Ramamoorthy (416) 941-9607 representing Respondent Taro Pharmaceuticals Inc. * no one appearing * representing Respondent Minister of Health Comments: The proposed s. 6(5)(b) Motion on behalf of the Respondent Taro will be heard at a Special Sitting in Ottawa on 18-SEP-2013 for a duration of 1 day; the parties will seek a Confidentiality Order prior to the filing of their Motion Records Minutes of Hearing entered in Vol. 883 page(s) 495 - 496 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 15-JUL-2013 directing that "A case management telephone conference will be held on 15-JUL-2013, immediately following the case management telephone conference in T-2024-12." (scheduled to commence at 3:00 p.m.) placed on file on 15-JUL-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 15-JUL-2013 re: Letters dated 10-JUL-2013 and 12-JUL-2013

Letter from Respondent dated 12-JUL-2013 in response to the letter from the Applicant dated July 12, 2013. The Respondent takes issue with several points raised in the Applicant's letter and advises that they will address these at the CMC on July 15, 2013. The Applicant states that this proceeding is in no way connected to the proceeding in T-2024-12 and submits that it would be inappropriate to merge or otherwise consolidate these cases. The Respondent advises that they remain available for a CMC following the CMC in T-2024-12 on July 15, 2013. received on 12-JUL-2013

Letter from Applicant dated 12-JUL-2013 in response to the letter received from Respondent, Taro on 10-JUL-2013 in T-2023-12 and with reference to Dr. Reddy's Laboratories Inc (T-2024-12). The Applicant raises objections with statements made in the July 10, 2013 letter (T-2023-12) and suggests that the during the CMC on July 15, 2013 to discuss Novartis' confidentiality motion in T-2024-12 the parties also discuss Taro's s. 6(5)(b) motion as well. In any event the Applicants believe that it would be best to address the issue of any Confidentiality Order in T-2023-12 after Novartis' Confidentiality Order motion in T-2024-12 has been resolved. received on 12-JUL-2013

Letter from Respondent Taro Pharmaceuticals Inc. dated 10-JUL-2013 further to the Directions dated 27-JUN-2013, advising that the parties have been unable to agree to a schedule for Taro's s. 6(5) Motion and requesting that the Court endorse the schedule proposed by Taro for the Motion... "Novartis has represented to Taro that it is seeking a Confidentiality Order in another proceeding in which it has filed identical evidence on the merits of the application (Court File No. T-2024-12). Taro is agreeable to await the issuance of a Confidentiality Order in that proceeding which can thereafter guide the form and content of a similar Order in this proceeding. We respectfully request that a Direction or Order issue in accordance with the schedule proposed above. We do not believe a case management conference is necessary, but if needed, we can make ourselves available anytime on July 12, 15 or 17..." received on 10-JUL-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 27-JUN-2013 directing that "The parties are expected to comply with paragraph 4 of the Scheduling Order by discussing with each other an appropriate schedule for filing such Motion for a Confidentiality Order as may be required, for serving responding evidence on the Motion, and for cross-examination, for filing a responding record and their mutual dates of availability for a hearing, without the need for a case management telephone conference. The Respondent is relieved of the obligation to file its Motion Record until an appropriate Motion for a Confidentiality Order has been filed and determined." placed on file on 27-JUN-2013 Confirmed in writing to the party(ies)

Letter from Respondent Taro Pharmaceuticals Inc. dated 27-JUN-2013 re: "...We write pursuant to the Order dated 13-FEB-2013, and hereby advise the Court that Taro intends to bring a section 6(5)(b) motion to dismiss this proceeding in its entirety. A Notice of Motion is attached to this letter. The Notice of Motion and the evidence in support of the motion will be served on the parties by the 3-JUL-2013 deadline. The Applicant served its evidence on the merits of the application on 3-JUN-2013. As much of the Applicant's evidence has been marked Confidential pursuant to the Protective Order, Taro is unable to file its section 6(5)(b) motion without a Confidentiality Order in place. We request a case management conference to discuss the issuance of a Confidentiality Order, as well as the scheduling of the motion including the period for cross-examination (if any) and exchange of memoranda. The corporate parties have the following mutual availabilities for a case management conference..." received on 27-JUN-2013

Solicitor's certificate of service on behalf of Livia Aumand confirming service of the Infrigement evidence of the Applicant upon the Resondent/Patentee, Roche Diagnosis GmbH., and Novartis AG by personal service on 31-MAY-2013 confirming service the infrigement evidence of the Applicant upon the Respondent, Taro Pharmaceuticals Inc and the Minister of Health by courier on 31-MAY-2013 filed on 03-JUN-2013

Acknowledgment of Receipt received from all parties with respect to Order Doc. 16 placed on file on 19-MAR-2013

Order dated 18-MAR-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 14-MAR-2013 Result: granted - Verification Order Filed on 18-MAR-2013 copies sent to parties entered in J. & O. Book, volume 1187 page(s) 107 - 108 Interlocutory Decision

Communication to the Court from the Registry dated 15-MAR-2013 re: Letter dated 14-MAR-2013

Letter from Applicant dated 14-MAR-2013 enclosing a draft verification order consented to by all parties, and requesting that the Order be issued without the need to file a formal Motion Record (see paragraph 2 of the Order dated 13-FEB-2013) received on 14-MAR-2013

Acknowledgment of Receipt received from all parties via email on February 13, 2013 with respect to Doc.15 placed on file on 13-FEB-2013

Order dated 13-FEB-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 06-FEB-2013 Result: 1. Taro Pharmaceuticals Inc. ("Taro") shall deliver its response to the request for disclosure related to the Taro Product sent by the Applicant on December 4, 2012 by February 15, 2013. 2. In the event that it is necessary for the Applicant to bring a motion pursuant to section 6(7) of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), a full motion record shall be served and filed by March 15, 2013. It shall be accompanied by a letter setting out a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 3. The Applicant's evidence on infringement shall be served by the later of (i) June 3, 2013; or (ii) within 90 days of the provision by Taro of any disclosure provided in response to the within request for production or in accordance with a motion filed as per paragraph 2. 4. In the event Taro seeks to bring a section 6(5) motion, the full motion record shall be served and filed within 30 days of service of the Applicant's evidence on infringement. It shall be accompanied by a letter setting out a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 5. If a section 6(5) motion is brought as per paragraph 4, Taro's evidence on infringement shall be served no later than 60 days following the dismissal of any section 6(5) motion. If no section 6(5) motion is brought, Taro's evidence shall be served no later than 90 days following the service of the Applicant's evidence on infringement. 6. Any motion for leave to serve reply evidence shall be served and filed within 20 days following the service of Taro's evidence on infringement. 7. The Applicant shall file a requisition for hearing within 20 days following the service of Taro's evidence on infringement. 8. In the event that it is necessary to bring a motion for a Confidentiality Order in the within proceeding, it shall be served and filed within 45 days following the service of Taro's evidence on infringement. 9. Cross-examinations shall be completed within 90 days following the service of Taro's evidence on infringement. 10. The parties shall advise the Court promptly of the date on which the last cross-examination transcript is received. 11. The Applicant's record shall be served and filed within 45 days of the receipt of the last cross-examination transcript. 12. The Respondent Taro's record shall be served and filed no later than 45 days following service of the Applicant's Record. Filed on 13-FEB-2013 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1183 page(s) 492 - 494 Interlocutory Decision

Communication to the Court from the Registry dated 07-FEB-2013 re: Letter dated 6-FEB-2013

Letter from Applicant dated 06-FEB-2013 on behalf of all parties, providing a proposed schedule further to the Directions dated 11-DEC-2012 received on 06-FEB-2013

Acknowledgment of Receipt received from all parties with respect to Protective Order Doc. 14 placed on file on 21-JAN-2013

Protective Order dated 21-JAN-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 16-JAN-2013 Result: granted "...[11] A Party who wishes to file Confidential Information shall apply to the Court by way of a Motion or such other procedure as the Court may designate, for a review by the Court for the purpose of determining whether the information can be filed as Confidential Information in accordance with Rule 151 of the Federal Courts Rules. The burden shall be on the Party asserting confidentiality. Subject to any Order or Direction of the Court, such information shall not be filed until the Court has made such determination. If the Confidential Information that a Party wishes to file is the Confidential Information of another Party, the Party wishing to file the Confidential Information shall give four weeks' notice in writing of its intention to do so in order that the Party whose Confidential Information is proposed to be filed may bring the appropriate Motion. ..." Filed on 21-JAN-2013 copies sent to parties entered in J. & O. Book, volume 1181 page(s) 81 - 89 Interlocutory Decision

Communication to the Court from the Registry dated 17-JAN-2013 re: Letter dated 16-JAN-2013 re: draft protective order

Letter from Applicant dated 16-JAN-2013 requesting that the Court issue a Protective Order in the form of the enclosed draft agreed to by the parties received on 16-JAN-2013

Written directions received from the Court: Mireille Tabib, Prothonotary dated 14-JAN-2013 directing that "Extension granted to February 11, 2013, as requested." placed on file on 15-JAN-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 09-JAN-2013 re: letter dated 8-JAN-2013

Letter from Respondent Taro Pharmaceuticals Inc. dated 08-JAN-2013 with the consent of the Applicant, requesting a one month extension of time for the parties to respond to the Directions dated 11-DEC-2012 received on 08-JAN-2013

Written directions received from the Court: Mireille Tabib, Prothonotary dated 11-DEC-2012 directing that "The parties shall, no later than 11-JAN-2013, either jointly or separately, file written submissions as to the following matters and issues: (a) Whether any Motion pursuant to Section 6(7) of the PM (NOC) Regulations is contemplated, and if so, a proposed schedule for filing the parties' respective Motion materials. (b) Whether any Motion for a Confidentiality Order is contemplated, and if so, a proposed schedule for filing the parties' respective Motion materials. (c) Whether any Motion pursuant to Section 6(5)(a) or (b) of the PM (NOC) Regulations is contemplated, and if so, the timeframe for bringing such Motion. (d) A proposed schedule for the further steps to be taken in this Application, including whether the parties have agreed to a partial or full reversal of the Order of filing evidence, and if not, whether any Motion to that effect is contemplated, together with, as the case may be, a proposed schedule for filing the parties' respective Motion materials on such a Motion. (e) Both counsel's joint availabilities to participate in a case management telephone conference to discuss the proposals, issues or matters listed above." placed on file on 11-DEC-2012 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 10-DEC-2012 re: newly case managed file

Proof of transmission by fax received from all parties with respect to Doc #11 (Order from CJC dated November 21, 2012) placed on file on 21-NOV-2012

Solicitor's certificate of service on behalf of Cheryl Cheung confirming service of doc. #12 upon Applicant Respondent by telecopier on 21-NOV-2012 filed on 21-NOV-2012

Notice of appearance on behalf of Taro Pharmaceuticals Inc. filed on 21-NOV-2012

Order dated 21-NOV-2012 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Status Review Result: It is ordered pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 21-NOV-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1175 page(s) 188 - 188 Interlocutory Decision

Affidavit of service of Erin McIntommy sworn on 14-NOV-2012 on behalf of Applicant confirming service of Doc. 1 upon the Respondent (Minister of Health) & Respondent Patentee (Novartis AG and Roche Diagnostics) by personal service on 08-NOV-2012 filed on 14-NOV-2012

Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of Doc.8 upon the Applicant and the Respondent Patentee (Novartis AG) by personal service on 14-NOV-2012 confirming service Doc. 8 upon the Respondent Taro Pharmaceuticals Inc. and Minister of Health by telecopier on 14-NOV-2012 filed on 14-NOV-2012

Notice of appearance on behalf of the Respondent Patentee, Roche Diagnostics filed on 14-NOV-2012

Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of doc. 6 upon the Applicant and Respondent Patentee (Roche Diagnostics) by personal service on 14-NOV-2012 confirming service doc. 6 upon the Respondents Taro Pharmaceuticals and Minister of Health by telecopier on 14-NOV-2012 filed on 14-NOV-2012

Notice of appearance on behalf of the Respondent Patentee (Novartis AG) filed on 14-NOV-2012

Affidavit of service of Natalie Sirota sworn on 12-NOV-2012 on behalf of Applicant confirming service of doc. 1 upon Respondent (Taro Pharmaceuticals Inc.) by personal service on 12-NOV-2012 filed on 14-NOV-2012

Affidavit of service of James Adeney sworn on 13-NOV-2012 on behalf of Respondent, Minister of Health confirming service of doc 3 upon all parties by telecopier on 13-NOV-2012 with Exhibits A filed on 13-NOV-2012

Notice of appearance on behalf of Respondent, Minister of Health filed on 13-NOV-2012

Service copy of Doc. No. 1 with proof of service upon Deputy Attorney General of Canada on 08-NOV-2012 filed on 08-NOV-2012

Notice of application and 2 copies with regard to S.55.2(4) of the Patent Act and s.6 of the Patented Medicines (NOC) Reg. filed on 08-NOV-2012 Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes